List of Danaher Executive and Leadership Team

Leadership Overview

Danaher has 10 executives leading key functions including strategy, finance, operations, and technology.

Driven by innovation, Danaher delivers integrated solutions across biotechnology, life sciences, and diagnostics, enabling global therapeutic product development and manufacturing through specialized equipment and services.

Leadership Roles at Danaher

President & Chief Executive Officer - Rainer Blair

Chief Financial Officer - Jeffrey Figg

Beckman Coulter Diagnostics Senior VP & Chief Financial Officer (Danaher Corporation) - Thomas Coffman

Chief Financial Officer & Global Vice President, Finance & Information Technology (Sciex) - Chris Apicerno

Senior Vice President and Group Chief Financial Officer, Diagnostics Platform - Ross Bell

Vice President Group Chief Financial Officer Life Sciences - Henry Carroll

Corporate Vice President & Chief Financial Officer (Asia) - Samuel Liao

Acting Chief Financial Officer & Director, Finance - Wang Donne

Chief Operating Officer, Ai & Technology - Nicholas Johnson

Director, Molecular Design AI Chief Revenue Officer Alliances - Ismet Dorange

Rainer Blair - President & Chief Executive Officer

Rainer Blair, the President & Chief Executive Officer at Danaher, directs the company's overarching strategy and operational execution across its diverse biotechnology, life sciences, and diagnostics sectors. Blair guides the enterprise in delivering integrated solutions that facilitate the global development and manufacture of therapeutic products. This leadership involves overseeing the design and production of specialized equipment, consumables, and services, addressing complex challenges in drug development, laboratory analysis, and clinical diagnostics. Blair ensures Danaher's bioprocess technologies and manufacturing support systems streamline therapeutic creation, encompassing cell culture media development, chromatography resins, filtration technologies, and single-use hardware. The Chief Executive Officer also champions the company's commitment to advancing analytical instrumentation, healthcare filtration, and genomic medicine offerings, solidifying Danaher's market position. Rainer Blair drives the company's mission to enable its customers to create life-changing innovations.

Jeffrey Figg - Chief Financial Officer

Jeffrey Figg, the Chief Financial Officer at Danaher, oversees the company's global financial operations, ensuring fiscal health and strategic resource allocation. Figg manages all aspects of financial planning, reporting, and analysis, supporting Danaher's extensive operations in biotechnology, life sciences, and diagnostics. This role involves optimizing financial strategies to enable the development and manufacture of therapeutic products worldwide. The Chief Financial Officer directs the financial integration of specialized equipment, consumables, and services, crucial for addressing complex challenges in drug development and clinical diagnostics. Figg's responsibilities include managing capital allocation for bioprocess technologies and manufacturing support systems, ensuring efficient streamlining of therapeutic creation. By providing robust financial oversight, Jeffrey Figg supports the company's advanced analytical instrumentation, healthcare filtration, and genomic medicine initiatives, driving sustainable growth and shareholder value.

Thomas Coffman - Beckman Coulter Diagnostics Senior VP & Chief Financial Officer (Danaher Corporation)

Thomas Coffman, the Beckman Coulter Diagnostics Senior VP & Chief Financial Officer (Danaher Corporation) at Danaher, directs financial strategy and operations specifically for the Beckman Coulter Diagnostics segment. Coffman ensures robust financial management supporting the development and manufacture of critical diagnostic solutions globally. This leadership involves overseeing financial planning and analysis for specialized equipment, consumables, and services that address complex challenges in clinical diagnostics. The Senior VP & Chief Financial Officer manages capital deployment for bioprocess technologies and manufacturing support systems within this division, streamlining therapeutic creation and analysis. Thomas Coffman's financial acumen supports the advancement of laboratory-scale protein purification tools and analytical instruments, reinforcing Beckman Coulter's role in healthcare. Coffman drives financial performance and strategic growth for the diagnostics platform.

Chris Apicerno - Chief Financial Officer & Global Vice President, Finance & Information Technology (Sciex)

Chris Apicerno, the Chief Financial Officer & Global Vice President, Finance & Information Technology (Sciex) at Danaher, manages comprehensive financial and IT operations for the Sciex division. Apicerno ensures strategic financial planning and robust IT infrastructure to support Sciex's advanced analytical instrumentation and life sciences solutions. This dual role involves optimizing financial performance and technological capabilities to drive innovation in mass spectrometry, genomics, and microscopy. The Chief Financial Officer & Global Vice President oversees capital allocation for critical consumables such as antibodies and reagents, alongside genomic medicine offerings. Chris Apicerno's leadership ensures seamless integration of financial and IT strategies, enhancing operational efficiency and supporting the development of cutting-edge research tools and industrial filtration systems, thereby reinforcing Sciex's market leadership.

Ross Bell - Senior Vice President and Group Chief Financial Officer, Diagnostics Platform

Ross Bell, the Senior Vice President and Group Chief Financial Officer, Diagnostics Platform at Danaher, leads financial strategy and oversight for the company's diagnostics business segment. Bell ensures optimal financial performance and resource allocation across the diagnostics portfolio, supporting the delivery of integrated solutions for clinical diagnostics. This role involves managing financial planning and analysis for specialized equipment, consumables, and services critical to laboratory analysis and healthcare. The Senior Vice President and Group Chief Financial Officer directs financial operations that streamline the development and manufacture of diagnostic technologies. Ross Bell's financial leadership supports the advancement of analytical instruments and healthcare filtration solutions, reinforcing the diagnostics platform's contribution to global health outcomes and driving profitable growth.

Henry Carroll - Vice President Group Chief Financial Officer Life Sciences

Henry Carroll, the Vice President Group Chief Financial Officer Life Sciences at Danaher, directs financial strategy and operations for the company's extensive life sciences division. Carroll ensures robust financial management and resource allocation to support advanced analytical instrumentation, genomics platforms, and microscopy solutions. This leadership role involves optimizing financial planning and analysis for critical consumables, reagents, and genomic medicine offerings, including custom nucleic acid products. The Vice President Group Chief Financial Officer oversees financial operations that streamline research and industrial applications. Henry Carroll's financial expertise supports the development of industrial filtration systems and protein products, driving innovation and operational efficiency across the life sciences sector and contributing to Danaher's overall market impact.

Samuel Liao - Corporate Vice President & Chief Financial Officer (Asia)

Samuel Liao, the Corporate Vice President & Chief Financial Officer (Asia) at Danaher, leads financial strategy and operations across the company's Asian markets. Liao ensures fiscal discipline and strategic investment to support Danaher's diverse operations in biotechnology, life sciences, and diagnostics throughout the region. This role involves managing financial planning and analysis for specialized equipment, consumables, and services tailored to Asian market needs. The Corporate Vice President & Chief Financial Officer oversees financial integration of bioprocess technologies and manufacturing support systems, streamlining therapeutic creation and diagnostics development. Samuel Liao's financial oversight drives regional growth and operational efficiency, reinforcing Danaher's global presence and commitment to delivering impactful solutions across Asia.

Wang Donne - Acting Chief Financial Officer & Director, Finance

Wang Donne, the Acting Chief Financial Officer & Director, Finance at Danaher, provides critical financial leadership and management for designated operational areas. Donne oversees financial planning, reporting, and analysis, ensuring accuracy and compliance across relevant business units. This role involves supporting the financial aspects of specialized equipment, consumables, and services that address complex challenges in drug development and diagnostics. The Acting Chief Financial Officer & Director, Finance contributes to the financial oversight of bioprocess technologies and manufacturing support systems, aiding in the streamlining of therapeutic creation. Wang Donne's financial acumen supports key initiatives within Danaher, ensuring sound fiscal management and contributing to the company's overall operational objectives and financial stability.

Nicholas Johnson - Chief Operating Officer, Ai & Technology

Nicholas Johnson, the Chief Operating Officer, Ai & Technology at Danaher, spearheads the integration and advancement of artificial intelligence and technology across the company's operations. Johnson directs the strategic implementation of AI and cutting-edge technologies to enhance Danaher's offerings in biotechnology, life sciences, and diagnostics. This role involves optimizing the design and deployment of specialized equipment, consumables, and services, leveraging technology to solve complex challenges in drug development and clinical diagnostics. The Chief Operating Officer, Ai & Technology oversees the technological infrastructure supporting bioprocess technologies and manufacturing systems, streamlining therapeutic creation. Nicholas Johnson drives innovation in advanced analytical instrumentation, healthcare filtration, and genomic medicine through strategic technology adoption, ensuring Danaher remains at the forefront of scientific advancement and operational efficiency.

Ismet Dorange - Director, Molecular Design AI Chief Revenue Officer Alliances

Ismet Dorange, the Director, Molecular Design AI Chief Revenue Officer Alliances at Danaher, cultivates strategic revenue-generating partnerships and alliances, particularly focusing on molecular design and AI applications. Dorange drives business development initiatives that enhance Danaher's capabilities in biotechnology, life sciences, and diagnostics. This leadership involves forging collaborations to deliver integrated solutions that enable the development and manufacture of therapeutic products globally. The Director, Molecular Design AI Chief Revenue Officer Alliances focuses on expanding market reach through strategic alliances for specialized equipment, consumables, and services. Dorange's efforts support the integration of advanced technologies within bioprocess development and manufacturing systems, streamlining therapeutic creation. Ismet Dorange's strategic alliance building strengthens Danaher's position in advanced analytical instrumentation and genomic medicine offerings.

Explore Leadership Teams in Manufacturing

Broad Institute

Founded in 2004, Broad Institute researches biology and new treatments for human diseases by using genomics to find new therapies. They are located in Cambridge, Massachusetts.

Company Leadership

Urban Institute

The Urban Institute operates as a nonpartisan research organization committed to generating rigorous analysis and evidence-based insights on critical social and economic policy questions. Through empirical research and data-driven investigation, the organization works to inform public discourse and guide policymakers toward solutions that address complex societal challenges. The institute's work spans multiple dimensions of policy analysis, examining issues that directly affect communities and individuals across diverse socioeconomic circumstances. The organization maintains a multidisciplinary approach to research, bringing together economists, social scientists, and policy experts who collaborate to produce comprehensive studies and evaluations. This collaborative model enables the institute to examine interconnected policy challenges from multiple perspectives, generating nuanced findings that reflect the complexity of real-world problems. The research teams conduct original data collection, statistical analysis, and longitudinal studies designed to track outcomes and measure the effectiveness of various policy interventions. Urban Institute research addresses a broad spectrum of policy domains, including economic opportunity, education systems, health care access, housing markets, and government effectiveness.

Company Leadership

Jefferson Lab

Founded in 1984, the Jefferson Lab is headquartered in Newport News, Virginia. They conduct basic research of the atom's nucleus using the lab's unique particle accelerator, known as the Continuous Electron Beam Accelerator Facility (CEBAF).

Company Leadership

LGC

LGC is a life sciences measurement and testing company providing laboratory services, reference materials, analytical testing products and services along with genomics solutions for the pharmaceutical, food, agricultural biotechnology, government, sports, and academia industries. The company was founded in 1996 and is headquartered in Middlesex, United Kingdom.

Company Leadership

Frequently Asked Questions Regarding Danaher Top Executives and Leadership Team

Who leads Danaher?

Danaher is led by Rainer Blair (President & Chief Executive Officer), along with executives such as Jeffrey Figg (Chief Financial Officer) and Thomas Coffman (Beckman Coulter Diagnostics Senior VP & Chief Financial Officer (Danaher Corporation)).

Who is part of Danaher’s executive team?

The executive team of Danaher includes leaders such as Rainer Blair (President & Chief Executive Officer), Jeffrey Figg (Chief Financial Officer), Thomas Coffman (Beckman Coulter Diagnostics Senior VP & Chief Financial Officer (Danaher Corporation)) and other senior executives.

How many executives does Danaher have?

Danaher has 10 executives leading key business areas.

What roles are included in Danaher’s leadership team?

The leadership team of Danaher includes roles such as President & Chief Executive Officer, Chief Financial Officer, Beckman Coulter Diagnostics Senior VP & Chief Financial Officer (Danaher Corporation), Chief Financial Officer & Global Vice President, Finance & Information Technology (Sciex), Senior Vice President and Group Chief Financial Officer, Diagnostics Platform.